Detalles de la búsqueda
1.
Platelets and tyrosine kinase inhibitors: clinical features, mechanisms of action, and effects on physiology.
Am J Physiol Cell Physiol
; 323(4): C1231-C1250, 2022 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35938677
2.
Assessment of the effects of Syk and BTK inhibitors on GPVI-mediated platelet signaling and function.
Am J Physiol Cell Physiol
; 320(5): C902-C915, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33689480
3.
Effect of antiplatelet agents and tyrosine kinase inhibitors on oxLDL-mediated procoagulant platelet activity.
Blood Adv
; 7(8): 1366-1378, 2023 04 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36219587
4.
Thrombotic events in patients using cyclin dependent kinase 4/6 inhibitors, analysis of existing ambulatory risk assessment models and the potential influences of tumor specific risk factors.
Curr Probl Cancer
; 46(2): 100832, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35034766
5.
Revised model of the tissue factor pathway of thrombin generation: Role of the feedback activation of FXI.
J Thromb Haemost
; 20(6): 1350-1363, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35352494
6.
Ibrutinib Inhibits BMX-Dependent Endothelial VCAM-1 Expression In Vitro and Pro-Atherosclerotic Endothelial Activation and Platelet Adhesion In Vivo.
Cell Mol Bioeng
; 15(3): 231-243, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35611166
7.
The Toll-Like Receptor 2 Ligand Pam2CSK4 Activates Platelet Nuclear Factor-κB and Bruton's Tyrosine Kinase Signaling to Promote Platelet-Endothelial Cell Interactions.
Front Immunol
; 12: 729951, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34527000
Resultados
1 -
7
de 7
1
Próxima >
>>